ArticleJournal of advanced pharmaceutical technology & research
Bacterial and antibiotic susceptibility test patterns and quality of life of diabetic foot ulcer patients.
Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recent progress of plant-derived extracellular vesicle-like nanoparticles integrated with biomaterials for skin repair.Journal of nanobiotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic resistance is a growing concern in the treatment of diabetic foot ulcers. To address this, this study analyzed antibiotic usage patterns, microbial profiles, antimicrobial susceptibility, and patient quality of life (QoL). This was a descriptive observational study. This study collected data prospectively at Bojonegoro Regional Hospital between October 2022 and January 2023. Of the 66 patients, all of them exhibited bacterial growth. Microbial sensitivity profiles were categorized as gram-positive in 21 patients (32%), gram-negative in 38 patients (58%), gram-positive - gram-positive in 1 patient (2%), gram-negative - gram-negative in 2 patients (3%), and gram-positive - gram-negative in 4 patients (5%). The use of antibiotics is sensitive to gram-positive drugs, such as: cefepime, ceftriaxone, imipenem, and meropenem. Levofloxacin and imipenem both work 100% in gram-negative bacteria. Antibiotic usage overall is 159.05 DDD/100 patient days. Of the 11 highest domains, 33 patients (50.0%) have a good QoL, while 19 patients (28.8%) have poor QoL. A comprehensive approach is necessary for the effective management of diabetic foot wound infections, and family support is essential for the improved patient's QoL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.